跳至主要内容
临床试验/NCT03443479
NCT03443479已完成不适用

Retrospective Cohort Study of Patients With Type II (Hypercapnic) Respiratory Failure Treated With High-flow Oxygen Therapy Versus Non-invasive Ventilation With BiPAP

Hôpital de Verdun1 个研究点 分布在 1 个国家目标入组 324 人开始时间: 2015年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
324
试验地点
1
主要终点
Failure of initial treatment (combined outcome)

研究概览

简要总结

A retrospective cohort study of all patients treated for type II (hypercapnic) respiratory failure with either High-Flow Oxygen Therapy or Non-Invasive Ventilation in a general adult hospital.

详细描述

We will compare various clinically relevant outcomes in patients treated for type II (hypercapnic) acute respiratory failure (ARF) with either High-Flow Nasal Cannula (HFNC) or Non-Invasive Ventilation (NIV) in a general adult hospital.

All patients treated with HFNC were treated with an Optiflow device (Fisher&Paykel). Various Bilevel positive airway pressure (BiPAP) devices were used during the study period.

All ventilatory parameters were set according to the treating physicians' preferences.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients treated with respiratory failure not responding to conventional supplemental oxygen therapy
  • Blood venous gas showing partial pressure of carbon dioxide>50 mmHg before beginning therapy with either NIV or HFNC

排除标准

  • Lack of records of the primary outcome
  • End-of-life care
  • Lack of gas before the beginning of NIV or HFNC

结局指标

主要结局

Failure of initial treatment (combined outcome)

时间窗: 48 hours post intervention

Combined outcome of death or intubation or transition to another treatment modality or unplanned resumption of respiratory support

Death at 48h

时间窗: 48 hours post intervention

Mortality in the 48h following the initial intervention

次要结局

  • Incidence of endotracheal intubation(For the whole length of hospital stay, up to a maximum of one year.)
  • Length of stay(For the whole length of hospital stay, up to a maximum of one year.)
  • Mortality at 7d(7 days post intervention)
  • Duration of endotracheal intubation(For the whole length of hospital stay, up to a maximum of one year.)
  • Incidence of intervention change(For the whole length of hospital stay, up to a maximum of one year.)

研究者

发起方
Hôpital de Verdun
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验